BRCC3 Antibody

Lys-63-specific deubiquitinase BRCC36, Mouse Anti Human
Cat. No.
BT14433
Source
Synonyms
Lys-63-specific deubiquitinase BRCC36, BRCA1-A complex subunit BRCC36, BRISC complex subunit BRCC36, BRCA1/BRCA2-containing complex subunit 3, BRCA1/BRCA2-containing complex subunit 36, BRCC3, BRCC36, C6.1A, CXorf53, C6.1A, RP11-143H17.2.
Appearance
Purity
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Product Specs

Introduction
BRCC3, a subunit of the BRCA1-BRCA2-containing complex (BRCC), functions as an E3 ubiquitin ligase. It is believed to play a role in the cellular response to ionizing radiation and the progression through the G2/M checkpoint.
Formulation
The antibody is supplied at a concentration of 1mg/ml in a solution of PBS at pH 7.4 with 0.1% sodium azide.
Storage Procedures
For short-term storage (up to 1 month), the antibody should be kept at 4°C. For longer storage durations, it is recommended to store at -20°C. Repeated freeze-thaw cycles should be avoided.
Stability / Shelf Life
The antibody has a shelf life of 12 months when stored at -20°C and 1 month when stored at 4°C.
Applications
The BRCC3 antibody has been validated for use in ELISA and Western blot applications, demonstrating its specificity and reactivity. However, it is recommended to optimize the antibody concentration for each specific application. For Western blot analysis, a dilution range of 1:1000 to 1:2000 is suggested, with an initial starting dilution of 1:1000.
Synonyms
Lys-63-specific deubiquitinase BRCC36, BRCA1-A complex subunit BRCC36, BRISC complex subunit BRCC36, BRCA1/BRCA2-containing complex subunit 3, BRCA1/BRCA2-containing complex subunit 36, BRCC3, BRCC36, C6.1A, CXorf53, C6.1A, RP11-143H17.2.
Purification Method
BRCC3 antibody was purified from mouse ascitic fluids by protein-G affinity chromatography.
Type
Mouse Anti Human Monoclonal.
Clone
PAT3B1AT.
Immunogen
Anti-human BRCC3 mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with recombinant human BRCC3 amino acids 1-316 purified from E. coli.
Ig Subclass
Mouse IgG1 heavy chain and κ light chain.

Product Science Overview

Background of Lys-63-specific Deubiquitinase BRCC36

Lys-63-specific deubiquitinase BRCC36 is a crucial enzyme involved in the regulation of ubiquitination, a process that tags proteins for degradation or other cellular functions. BRCC36 is part of the BRCA1-A complex, which includes RAP80, CCDC98/ABRAXAS, BRCC45/BRE, MERIT40/NBA1, BRCC36, and BRCA1 . This complex specifically recognizes and removes Lys-63-linked ubiquitin chains from histones H2A and H2AX at DNA damage sites, facilitating the recruitment of the BRCA1-BARD1 heterodimer to double-strand breaks (DSBs) in DNA .

BRCC36 plays a significant role in maintaining genomic stability by participating in DNA repair processes. It is a member of the JAMM/MPN+ family of zinc metalloproteases, which are known for their ability to cleave Lys-63-linked polyubiquitin chains . This specific activity is crucial for the regulation of protein degradation and signaling pathways within the cell.

Role in Multiple Myeloma

Recent studies have highlighted the importance of BRCC36 in the context of multiple myeloma (MM), a type of hematological malignancy. BRCC36 has been shown to enhance the sensitivity of MM cells to lenalidomide, an immunomodulatory drug (IMiD), by inhibiting the lysosomal degradation of cereblon (CRBN) . CRBN is a substrate receptor of the cullin 4-RING E3 ligase (CRL4) complex, which promotes the ubiquitination and degradation of target proteins, thereby inhibiting the proliferation of myeloma cells .

Biochemical experiments have demonstrated that BRCC36, within the BRISC complex, protects CRBN from lysosomal degradation by specifically cleaving the K63-linked polyubiquitin chain on CRBN . This protection allows for the upregulation of CRBN, enhancing the efficacy of lenalidomide in treating multiple myeloma .

Mouse Anti-Human Antibodies

Mouse anti-human antibodies are secondary antibodies generated by immunizing mice with human immunoglobulins. These antibodies are affinity-purified and have well-characterized specificity for human immunoglobulins, making them useful in various detection, sorting, and purification applications . Secondary antibodies offer increased versatility and sensitivity through signal amplification, as multiple secondary antibodies can bind to a single primary antibody .

Mouse anti-human antibodies are commonly used in techniques such as ELISA, Western Blot, Flow Cytometry, and Immunohistochemistry . They can be conjugated with various labels, such as HRP, AP, fluorescence, or biotin, to facilitate detection and analysis .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.